Back to search
FDAFDA · Food and drugs·Recall number Z-2533-2024

Verigene Gram Positive Blood Culture (BC-GP) Nucleic Acid Test

Published August 14, 2024 · Recall initiated: June 20, 2024

Summary

FDA records medical device Class II recall Z-2533-2024, published August 14, 2024 and initiated June 20, 2024. Recalling firm: Luminex Corporation; Status: Ongoing; Reported quantity: 1,100 kits; Lot: GTIN Number: 00840487101575; Catalog Number: 20-006-018; Lot Number: 031824018A; Expiration Date: 09/16/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential for defective test cartridges which may result in false positive results for the Staphylococcus lugdunensis and Enterococcus faecium targets.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Luminex Corporation
Distributor
US Nationwide distribution including in the states of AZ, CA, CO, DE, FL, GA, IA, IL, KY, MD, MI, MN, MO, MS, NE, NV, OH, OK, SC, TN, TX, VA, VT, WA, WV.
Lot
GTIN Number: 00840487101575; Catalog Number: 20-006-018; Lot Number: 031824018A; Expiration Date: 09/16/2024
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Verigene Gram Positive Blood Culture (BC-GP) Nucleic Acid Test recalled?

Yes. FDA published recall Z-2533-2024 on August 14, 2024. Reported hazard: Potential for defective test cartridges which may result in false positive results for the Staphylococcus lugdunensis and Enterococcus faecium targets.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail